Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Buy
12,014
+200
+2% +$44.4K 0.13% 150
2025
Q4
$1.91M Buy
11,814
+26
+0.2% +$4.51K 0.08% 214
2025
Q3
$1.78M Buy
11,788
+1,957
+20% +$261K 0.08% 230
2025
Q2
$1.26M Sell
9,831
-3,216
-25% -$313K 0.06% 282
2025
Q1
$942K Buy
13,047
+6,285
+93% +$669K 0.05% 341
2024
Q4
$768K Buy
6,762
+527
+8% +$62.6K 0.04% 390
2024
Q3
$620K Buy
6,235
+610
+11% +$50.6K 0.03% 435
2024
Q2
$487K Buy
5,625
+1,060
+23% +$96.5K 0.03% 495
2024
Q1
$373K Buy
+4,565
New +$287K 0.02% 597

Other funds holding VRT

Moors & Cabot's VRT Position: Q1 2026 in Review

Moors & Cabot increased its Vertiv (VRT) stake by 1.7% in Q1 2026, buying an estimated $44.4K and bringing the position to 12,014 shares worth $3.01M. The position accounts for 0.13% of the portfolio, ranked #150.

Moors & Cabot first reported a position in VRT in Q1 2024 and has held it in 9 quarters since. 1,830 funds tracked by Wall St. Rank hold VRT as of Q1 2026.

  • Moors & Cabot held 12,014 shares of Vertiv worth $3.01M as of Q1 2026.
  • Moors & Cabot bought 200 Vertiv shares in Q1 2026, an estimated $44.4K.
  • Vertiv made up 0.13% of Moors & Cabot's portfolio in Q1 2026, its #150 holding.
  • Moors & Cabot first reported a position in Vertiv in Q1 2024 and has held it in 9 quarters since.
  • 1,830 funds tracked by Wall St. Rank held Vertiv as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.